Healthy cells can impact tumour progression during embryonic development

Avian embryo model of neuroblastoma

12-May-2022 - France

Half of childhood cancers arise during the development of the human embryo, which greatly complicates research into these diseases. The team of Valérie Castellani, CNRS senior researcher at the Mechanisms in Integrated Life Sciences (MeLiS) laboratory (CNRS / INSERM / Claude Bernard Lyon 1 University) has thus developed a model that optimally simulates the human embryonic environment by grafting human cancer cells into a chick embryo. This new method, for which Castellani won the 2018 CNRS Medal of Innovation, makes it possible to explore the mechanisms of metastasis, i.e. how cancer cells spread throughout the body, and to investigate the role of normal cells in the behaviour of malignant ones. Using the chick embryo model, Castellani’s team, in partnership with the Biology and Biotechnology for Health (BioSanté) laboratory  (CEA / INSERM / Université Grenoble Alpes) and the Lyon Paediatric Haematology and Oncology Institute (Centre Léon Bérard / Hospices Civils de Lyon)1, trained their attention on neuroblastomas, paediatric cancers originating in neurons that have yet to mature. The metastatic forms of these cancers are extremely aggressive. Published in Nature Communications and led by Dounia Ben Amar, a PhD student cosupervised by CNRS researcher Céline Delloye-Bourgeois, the study found that certain healthy, developing neurons promote metastatic behaviour in the neuroblastoma cells with which they come into contact.  It not only shows that normal cells can play a part in tumour progression during embryonic development,  but also illustrates the importance of better understanding the unique developmental environment within which cancers of embryonic origin form.

© MeLiS_Equipe Castellani

Caption Avian embryo model of neuroblastoma. Physiological signals from embryonic tissues in which tumours develop cause some cells to acquire more aggressive traits, break away, and spread to remote sites, seeding metastases.

Original publication

Other news from the department science

Most read news

More news from our other portals

Last viewed contents

QIAGEN completes second U.S. submission for companion diagnostic to guide treatment decisions in colorectal cancer

Researchers unravel the social network of immune cells - “Macrophages are real chatterboxes”

Researchers unravel the social network of immune cells - “Macrophages are real chatterboxes”

Genzyme to Build Additional Plant to Support Growth of Myozyme and Lumizyme

Siemens and Merck Collaborate to Boost Machine-to-Machine Trust in Industrial Value Chains

Siemens and Merck Collaborate to Boost Machine-to-Machine Trust in Industrial Value Chains

How to shoot the messenger - EMBL scientists shed light on cellular communication systems involved in neurodegeneration, cancer and cardiovascular disease

Washing machine bacteria: the smell comes from the rubber seal

Washing machine bacteria: the smell comes from the rubber seal

CTC – Centro de Tecnologia Canavieira – and BASF enter technical cooperation agreement in sugarcane - German-based BASF and Brazilian research center enter cooperation in plant biotechnology

Dr._Williams'_Pink_Pills_for_Pale_People

How dangerous are nanoplastics for babies in the womb? - The focus is on nanoplastic particles, which could lead to the development of a hypersensitive immune system in the child

How dangerous are nanoplastics for babies in the womb? - The focus is on nanoplastic particles, which could lead to the development of a hypersensitive immune system in the child

Chemists create eco-friendly method to make chlorine-based materials for drugs and chemicals - “Our method uses sustainable, low-cost catalysts and operates at room temperature with gentle blue light”

Chemists create eco-friendly method to make chlorine-based materials for drugs and chemicals - “Our method uses sustainable, low-cost catalysts and operates at room temperature with gentle blue light”

Tecan sells sample management business to US firm NEXUS Biosystems - Tecan is focusing its growth strategy on its Life Sciences core business

List_of_subjects_in_Gray's_Anatomy:_V._Angiology